Ireland· IE-PA-EU/1/98/091/009-012
Kinzalmono 20 mg tablets
A irbesartan und diuretika product containing telmisartan, registered in Ireland by Bayer AG. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Irbesartan und diuretika is registered in 13 of 19 countries.
Countries holding a registration under ATC C09DA04 (irbesartan und diuretika), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Irbesartan und diuretika · ATC C09DA04
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Telmisartan
- Manufacturer
- Bayer AG
- Country
- Ireland (IE)
- ATC code
- C09DA04
- ATC class
- Irbesartan und Diuretika
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/98/091/009-012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for irbesartan und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Irbesartan und diuretika · interactions on record
80 records
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Irbesartan und diuretika in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMicardis 20mg tabletsLexon (UK) Ltd
- United StatestelmisartanAscend Laboratories, LLC
- SpainMICARDIS 20 MG COMPRIMIDOSBoehringer Ingelheim International Gmbh
- NetherlandsKinzalmono 20 mg, tablettenBayer AG
- CzechiaMICARDISBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- FinlandKinzalmonoBayer AG
- SwedenKinzalmono 20 mg TablettBayer AG
- ItalyTELMISARTAN AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Actelsar, Telmicard
- Belgium · Telmisartan Eg, Telmisartan Teva
- Bulgaria · Telsart, Tезео
- Cyprus · Telmisartan Jubilant
- Czechia · Telmisartan Egis, Telmisartan Ratiopharm
- Germany · Telmisartan 1 A Pharma, Telmisartan Abz
- Denmark · Telmisartan Medical Valley, Telmisartan Stada
- Estonia · Telmisartaan Amarox, Telmisartan Ratiopharm
- Spain · Telmark, Telmisartán Almus
- Finland · Telmark, Telmisartan Amarox
- France · Telmisartan Amarox, Telmisartan Arrow
- United Kingdom (Northern Ireland) · Telmisartan Accord Healthcare, Telmisartan Amarox
- Hungary · Tanydon, Telmisartan Egis
- Iceland · Kinzalmono, Micardis
- Italy · Telmisartan Almus, Telmisartan Alter
- Liechtenstein · Kinzalmono, Micardis
- Lithuania · Telmisartan Ingen Pharma, Telmisartan Inteli
- Luxembourg · Telmisartan Eg, Telmisartan Micro Labs
- Latvia · Telmisartan Ratiopharm, Tezeo
- Netherlands · Telmisartan 1a Pharma, Telmisartan Amarox
- Norway · Kinzalmono, Micardis
- Poland · Actelsar, Polsart
- Portugal · Diterpris, Mirpresoc
- Romania · Tezeo
- Sweden · Telmark, Telmisartan Amarox
- Slovakia · Telmark, Telmisartan Egis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3da591f-d371-42a8-bfb4-721456e59aa0 GET /v1/drugs/b3da591f-d371-42a8-bfb4-721456e59aa0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"C09DA04"
],
"strength": null,
"pa_number": "EU/1/98/091/009-012",
"substances": [
"Telmisartan"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0049-003-014"
}See everything about irbesartan und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.